Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment-Reference-Cited by-同舟云学术

Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment

Published:2020-03-29 Issue:3 Volume:17 Page:323-333
ISSN:1738-2696
Container-title:Tissue Engineering and Regenerative Medicine
language:en
Short-container-title:Tissue Eng Regen Med

Author:

Jang Woong Bi,Ji Seung Taek,Park Ji Hye,Kim Yeon-Ju,Kang Songhwa,Kim Da Yeon,Lee Na-Kyung,Kim Jin Su,Lim Hye Ji,Choi Jaewoo,Le Thi Hong Van,Ly Thanh Truong Giang,Rethineswaran Vinoth Kumar,Kim Dong Hwan,Ha Jong Seong,Yun Jisoo,Baek Sang Hong,Kwon Sang-Mo

Funder

Ministry of Health and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s13770-020-00244-w.pdf

Reference51 articles.

1. Bhatnagar A. Environmental determinants of cardiovascular disease. Circ Res. 2017;121:162–80.

2. Cohen BE, Edmondson D, Kronish IM. State of the art review: depression, stress, anxiety, and cardiovascular disease. Am J Hypertens. 2015;28:1295–302.

3. Moran AE, Roth GA, Narula J, Mensah GA. 1990–2010 Global cardiovascular disease Atlas. Glob Heart. 2014;9:3–16.